Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Applied Therapeutics, Inc. Director's Dealing 2019

May 14, 2019

34263_dirs_2019-05-13_34176482-6c4d-4fb8-98c3-4384bceef163.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: Vignola Mark J. (Chief Financial Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $12.93 2029-05-02 Common Stock (161594) Direct

Footnotes

F1: One-third (1/3rd) of the shares subject to the option shall vest on April 27, 2020, and one twenty-fourth (1/24th) of the remaining shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.